QuickView for 5,10-methylenetetrahydrofolate-dependent methyltransferase activity (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
2. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
3. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
4. Drug target sets for approved compounds
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)

There were no matches for 5,10-methylenetetrahydrofolate-dependent methyltransferase activity

1. Clinical Utility of Pharmacogenomics of Psychotropic Medications